Innovating Cell and Gene Therapy

CGI BIO LLC is a newly established biotech company dedicated to advancing the field of cell and gene therapy. With a strong emphasis on innovation and quality, CGI BIO aims to bridge the gap between cutting-edge research and scalable therapeutic solutions. Our team of seasoned professionals, equipped with extensive experience in biotechnology and gene therapy, ensures the company is poised to make a significant impact.

The global gene therapy market is forecasted to reach $35.67 billion by 2027, growing at a CAGR of 20.4%. CGI BIO LLC is positioned to capitalize on this growth through its strategic focus on product development, analytical services, and partnerships with key industry players. We anticipate delivering measurable returns to our investors within three years of operation.

Contact
A person in a laboratory setting works at a microscope station, wearing a white lab coat, blue hair net, and blue gloves. The environment is sterile, with scientific equipment organized around the station. A world map is visible on the wall, and a netted barrier separates sections of the lab.
A person in a laboratory setting works at a microscope station, wearing a white lab coat, blue hair net, and blue gloves. The environment is sterile, with scientific equipment organized around the station. A world map is visible on the wall, and a netted barrier separates sections of the lab.
A person wearing blue gloves is using a microscope. A petri dish is placed on the microscope stage, and the environment suggests a laboratory setting with equipment visible in the background.
A person wearing blue gloves is using a microscope. A petri dish is placed on the microscope stage, and the environment suggests a laboratory setting with equipment visible in the background.
Innovation

Accelerating development of transformative therapies for all.

Research

Services

contact@cgtbio.com

+1-845-800-5812

© 2024. All rights reserved.